VASOPRESSIN SECRETION IN THE NEW-ZEALAND GENETICALLY HYPERTENSIVE RAT

被引:13
作者
CROFTON, JT [1 ]
SHARE, L [1 ]
BAER, PG [1 ]
ALLEN, CM [1 ]
WANG, BC [1 ]
机构
[1] UNIV TENNESSEE,CTR HLTH SCI,DEPT PHARMACOL,MEMPHIS,TN 38163
关键词
D O I
10.3109/10641968109033716
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:975 / 989
页数:15
相关论文
共 16 条
[11]   VASOPRESSOR ROLE OF ADH IN PATHOGENESIS OF MALIGNANT DOC HYPERTENSION [J].
MOHRING, J ;
MOHRING, B ;
PETRI, M ;
HAACK, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (03) :F260-F269
[12]   NEUROHYPOPHYSEAL VASOPRESSOR PRINCIPLE - VASOPRESSOR HORMONE AS WELL AS ANTI-DIURETIC HORMONE [J].
MOHRING, J .
KLINISCHE WOCHENSCHRIFT, 1978, 56 :71-79
[13]   PLASMA VASOPRESSIN CONCENTRATIONS AND EFFECTS OF VASOPRESSIN ANTISERUM ON BLOOD-PRESSURE IN RATS WITH MALIGNANT 2-KIDNEY GOLDBLATT HYPERTENSION [J].
MOHRING, J ;
MOHRING, B ;
PETRI, M ;
HAACK, D .
CIRCULATION RESEARCH, 1978, 42 (01) :17-22
[14]  
PADFIELD PL, 1976, LANCET, V1, P1255
[15]   OBSERVATIONS ON RESPONSES OF RATS WITH SPONTANEOUS HYPERTENSION AND CONTROL RATS TO PRESSOR DRUGS AND TO HEXAMETHONIUM [J].
PHELAN, EL ;
SMIRK, FH ;
ERYETISHIR, I .
CIRCULATION RESEARCH, 1962, 10 (05) :817-+
[16]  
PHELAN EL, 1976, CLIN EXP PHARM PHY S, V3, P141